Biliary Cholangitis
📧 Sign up to get email alerts when something new happens for Biliary Cholangitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study [Phase 3]
A real-world Phase 3 trial evaluating fenofibrate in combination with ursodeoxycholic acid for primary biliary cholangitis is currently recr…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Fenofibrate in Primary Biliary Cholangitis: a Real World Study [Phase 3]
A Phase 3 real-world study evaluating fenofibrate for primary biliary cholangitis is currently recruiting, led by Xijing Hospital of Digesti…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial is evaluating fenofibrate in patients with compensated cirrhosis due to primary biliary cholangitis and is …
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis [Phase 3]
This clinical trial update notes a Phase 3 study evaluating fenofibrate combined with ursodeoxycholic acid in subjects with Primary Biliary …
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: The Value of Spleen Stiffness Measurement in Patients With PBC [NA]
This clinical trial update notes a study evaluating spleen stiffness measurement in patients with primary biliary cholangitis, which is curr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA [Phase 3]
This clinical trial update notes that CS0159 is in Phase 3 testing for primary biliary cholangitis patients with inadequate response or into…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy [Phase 3]
A Phase 3 FIREFLY trial evaluating fenofibrate as first-line therapy for Primary Biliary Cholangitis is currently recruiting. The trial is s…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC) [Phase 3]
Phase 3 trial update for seladelpar in primary biliary cholangitis; the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: Repeatability and Reproducibility of Multiparametric MRI
A clinical trial update reports on the repeatability and reproducibility of multiparametric MRI for evaluating liver diseases across several…
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary Cholangitis [EARLY_Phase 1]
This clinical trial update reports the completion of a Phase 1 pilot study evaluating the combination of fenofibrate and ursodeoxycholic aci…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: A Multicenter, Randomized, Controlled Trial of Prednisone Combined With Ursodeoxycholic Acid in the Treatment of Primary Biliary Cholangitis With Moderate to Severe Interface Hepatitis Characteristics [Phase 2, Phase 3]
A multicenter randomized trial evaluates prednisone combined with ursodeoxycholic acid for primary biliary cholangitis with moderate to seve…
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: Single Ascending Dose Study to Evaluate Safety Tolerability, Pharmacokinetics, and Pharmacodynamics of PVT201 in Healthy Subjects and Patients (PBC/PSC) [Phase 1]
Phase 1 single ascending dose study of PVT201 in healthy subjects and patients with primary biliary cholangitis (PBC) has completed; the sni…
-
FDA approval · 2025-11-21FDA Approved: URSODIOL — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for URSODIOL submitted by Strides Pharma Science Limited. This action updates the drug's approval st…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Participants With PBC [Phase 2]
Phase 2 trial evaluating the combination of obeticholic acid (OCA) and bezafibrate (BZF) for Primary Biliary Cholangitis has been terminated…
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate [Phase 3]
Phase 3 trial evaluating the safety and tolerability of a fixed-dose combination of obeticholic acid and bezafibrate in primary biliary chol…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Early Diagnosis of Primary Biliary Cholangitis (PBC) in Patients With Positive Anti-Mitochondrial Antibodies (AMA) and Normal Alkaline Phosphatase (ALP)
This clinical trial is currently recruiting to evaluate early diagnosis of Primary Biliary Cholangitis in patients with positive anti-mitoch…
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC [Phase 2]
A Phase 2 trial evaluating obeticholic acid in combination with bezafibrate for primary biliary cholangitis has completed, with results not …
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment. [Phase 2]
A Phase 2 clinical trial update evaluating pemafibrate (K-808) for primary biliary cholangitis in patients with inadequate response to UDCA …
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: TH104 for the Treatment of Pruritus in Primary Biliary Cholangitis [Phase 2]
Phase 2 clinical trial TH104 for treating pruritus in primary biliary cholangitis; status is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: RELIEF: Multimodal Prehabilitation to Treat Fatigue in Patients With Primary Biliary Cholangitis [NA]
This document reports on the RELIEF trial, a multimodal prehabilitation program aimed at treating fatigue in patients with Primary biliary c…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: PBC Long-term Outcomes Study
This multicenter prospective study is investigating long-term outcomes in primary biliary cholangitis and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Efficacy and Safety of Bezafibrate 400 mg and Bezafibrate 200 mg as Adjunctive Treatments in Patients With Primary Biliary Cholangitis and Non-optimal Biochemical Response to Ursodeoxycholic Acid Therapy [Phase 3]
A Phase 3 trial evaluating bezafibrate added to UDCA in primary biliary cholangitis patients with non-optimal biochemical response, currentl…
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: TruGraf Liver Gene Expression Serial Test
The TruGraf Liver Gene Expression Serial Test is enrolling by invitation at Washington University for autoimmune liver diseases, including a…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland
This clinical trial update assesses the health burden of primary biliary cholangitis in Switzerland. The study status indicates it is comple…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: Swiss Primary Biliary Cholangitis Cohort Study
A Swiss cohort study investigating Primary Biliary Cholangitis is currently recruiting participants.